Class information for: |
Basic class information |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Terms with highest relevance score |
rank | Category | termType | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|---|
1 | IMMUNOTHERAPY | authKW | 603819 | 11% | 17% | 2336 |
2 | DENDRITIC CELLS | authKW | 542266 | 10% | 17% | 2155 |
3 | MYELOID DERIVED SUPPRESSOR CELLS | authKW | 372613 | 2% | 65% | 376 |
4 | CANCER TESTIS ANTIGEN | authKW | 352958 | 1% | 77% | 303 |
5 | CANCER VACCINE | authKW | 317512 | 2% | 41% | 511 |
6 | CHIMERIC ANTIGEN RECEPTOR | authKW | 276725 | 1% | 72% | 254 |
7 | CANCER IMMUNOLOGY IMMUNOTHERAPY | journal | 256676 | 4% | 20% | 867 |
8 | CYTOKINE INDUCED KILLER CELLS | authKW | 253863 | 1% | 90% | 186 |
9 | JOURNAL OF IMMUNOTHERAPY | journal | 195309 | 2% | 28% | 469 |
10 | TUMOR ANTIGEN | authKW | 178139 | 1% | 41% | 288 |
Web of Science journal categories |
chi_square_rank | Category | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | Immunology | 128823 | 38% | 1% | 7859 |
2 | Oncology | 125595 | 41% | 1% | 8467 |
3 | Medicine, Research & Experimental | 33332 | 16% | 1% | 3296 |
4 | Hematology | 13126 | 8% | 1% | 1731 |
5 | Biotechnology & Applied Microbiology | 3344 | 7% | 0% | 1416 |
6 | Cell Biology | 3318 | 8% | 0% | 1756 |
7 | Cell & Tissue Engineering | 1763 | 1% | 1% | 199 |
8 | Genetics & Heredity | 1372 | 5% | 0% | 1004 |
9 | Pathology | 1288 | 3% | 0% | 598 |
10 | Urology & Nephrology | 129 | 2% | 0% | 315 |
Address terms |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | SURG BRANCH | 171958 | 2% | 33% | 348 |
2 | TUMOR IMMUNOL BIOL | 137880 | 1% | 43% | 213 |
3 | IMMUNOL | 92637 | 11% | 3% | 2277 |
4 | NEW YORK BRANCH | 90469 | 1% | 48% | 125 |
5 | LAUSANNE BRANCH | 65426 | 1% | 32% | 135 |
6 | CANC VACCINE DEV | 61841 | 0% | 73% | 56 |
7 | LUDWIG CANC | 61041 | 2% | 10% | 392 |
8 | U1015 | 60973 | 0% | 47% | 86 |
9 | CELLULAR GENET UNIT | 59597 | 0% | 55% | 72 |
10 | CLIN ONCOIMMUNOL | 59225 | 0% | 57% | 69 |
Journals |
chi_square_rank | term | chi_square | shrOfCwithTerm | shrOfTermInClass | termInClass |
---|---|---|---|---|---|
1 | CANCER IMMUNOLOGY IMMUNOTHERAPY | 256676 | 4% | 20% | 867 |
2 | JOURNAL OF IMMUNOTHERAPY | 195309 | 2% | 28% | 469 |
3 | ONCOIMMUNOLOGY | 107449 | 1% | 25% | 288 |
4 | JOURNAL OF IMMUNOLOGY | 39213 | 6% | 2% | 1203 |
5 | CLINICAL CANCER RESEARCH | 35396 | 3% | 4% | 604 |
6 | CANCER IMMUNOLOGY RESEARCH | 35289 | 1% | 21% | 109 |
7 | IMMUNOTHERAPY | 27989 | 1% | 15% | 120 |
8 | CANCER GENE THERAPY | 25437 | 1% | 9% | 182 |
9 | CANCER RESEARCH | 24502 | 4% | 2% | 815 |
10 | INTERNATIONAL JOURNAL OF CANCER | 21842 | 3% | 3% | 553 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Classes with closest relation at Level 2 |